Y104L
PDL BIOPHARMA INC
PDL BIOPHARMA INC Shareholders
Y104L Stock Holders 13F
- Number of holders*:
- 1
- AVG reported price*:
- $7.72
- Type:
- Common Stock
1 superinvestor reported owning Y104L (Common Stock) according to the gurus' 2013 Q2 report.
Who were the top gurus owning (Y104L) PDL BIOPHARMA INC in 2013 Q2?
The 1 super investor (holder) owning Y104L (by the percent (%) of portfolio) was Bill Miller - Miller Value Partners (0.04%) as of the 2013 Q2 report, among our followed gurus.
Which investors have ever held a position in Y104L historically?
Investors including Miller Value Partners and others have historically held positions in PDL BIOPHARMA INC — complete purchase and sale trading data is available for each.
The latest activities of the top Y104L shareholders among value investors are tracked each quarter, from new position openings and share additions to reductions and complete exits.
The historical data of Y104L holders is tracked quarterly, with each period reflecting disclosed ownership and position sizes.
Completely sold out
PDL BIOPHARMA INC price chart
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Number of holders: this represents holders from our curated fund list, not all the institutional holders in the world.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.